GMC guidance for end of life care
8th July 2010
New guidance, "Treatment and care towards the end of life: good practice in decision making", from the UK General Medical Council (GMC) came into effect on 1st July 2010 and replaces the booklet "Withholding and withdrawing life-prolonging treatments" (2002) and expands on the guidance in "Consent, patients and doctors making decisions together".
Recent news
- SMC accepts fentanyl single dose nasal spray
- NICE end of life care commissioning guide
- AWMSG approve tapentadol m/r for restricted use
- US FDA approve fentanyl sublingual spray
- NPSA Rapid Response Report on spinal connectors
- Update: anti-epileptics monograph
- NPC review m/r oxycodone/naloxone
- Prednisolone EC blister packs recalled from Teva
- Citalopram and escitalopram maximum daily doses restricted
- Extemporaneous thalidomide oral suspension stability study
News archive
- 2012
- 2011
- 2010
- 2009
- 2008
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000